Affable
发表于 2025-3-23 10:19:49
f 10 to 20% are not generally adequate to use as end points in phase 2 trials. In order to see reliable differences in survival in a phase 2 trial, a very striking treatment effect in a wellcontrolled setting is probably required. As a practical matter, to show benefit, most phase 3 studies of thera
撕裂皮肉
发表于 2025-3-23 17:43:29
http://reply.papertrans.cn/71/7019/701862/701862_12.png
GROSS
发表于 2025-3-23 21:58:32
me of the disease and the response to treatment. However, understanding the mechanisms used by tumor cells to evade the immune system could result in new therapeutic approaches for preventing and/or reversing these immune alterations and have the potential of improving the current results of immunotherapy trials.
暂时中止
发表于 2025-3-23 22:22:52
me of the disease and the response to treatment. However, understanding the mechanisms used by tumor cells to evade the immune system could result in new therapeutic approaches for preventing and/or reversing these immune alterations and have the potential of improving the current results of immunotherapy trials.
细菌等
发表于 2025-3-24 04:54:26
dies or ligands that block negative signals (CTLA4) or provide costimulatory signals (4-1BB, OX40) will be extended or initiated soon. The next several years should prove particularly informative as trials incorporating combinations of strategies make their way to the clinic.
Pedagogy
发表于 2025-3-24 09:47:04
h may contribute to inadequate phase 3 trials even when based on positive phase 2 data. However, even with well designed trials, rational vaccine development beyond the empiric evaluation of individual products will require a deeper understanding of human tumor immunobiology.
dilute
发表于 2025-3-24 11:57:18
http://reply.papertrans.cn/71/7019/701862/701862_17.png
cathartic
发表于 2025-3-24 16:34:19
ll infiltration and tumor destruction by monitoring soluble factors and tumor growth. Human tumors engineered in 3D collagen scaffolds are excellent in vitro surrogates for avascular tumor stages allowing integrated analyses of the antitumor efficacy of cancer specific immunotherapy in situ.
foppish
发表于 2025-3-24 20:05:46
he beginning of the 20th century, vaccines for typhoid fever, rabies, polio, plaque and diphtherias were in use, and nowadays we are equipped with effectivevaccinesagainstmorethan20infectiousdiseasessuchasmeningitis,rubella, whooping cough, rabies, and hepat978-1-4419-5479-4978-0-387-27545-1Series ISSN 0927-3042 Series E-ISSN 2509-8497
Dislocation
发表于 2025-3-25 01:41:27
most aggressive malignant primary brain tumor in humans, glioblastoma multiforme. With comprehensive and cutting-edge information on therapeutic interventions and on the correct diagnosis of relevant neoplasms,978-94-024-0702-0978-94-007-5958-9